Trustlife Therapeutics
Trustlife Therapeutics offers an AI-powered platform that speeds up drug discovery from target to preclinical. It combines the Trustlife AI system with advanced systems biology and big data to model biology and identify viable targets. The platform supports end-to-end workflows, including target discovery, hit identification, lead optimization, and preclinical development. Built as a B2B solution for biopharma and research organizations, it leverages causal AI and a scalable data infrastructure. The company aims to scale drug discovery across major therapeutic areas such as neurodegeneration, oncology, inflammation, and muscle-wasting diseases.
Trustlife Therapeutics
Trustlife Therapeutics offers an AI-powered platform that speeds up drug discovery from target to preclinical. It combines the Trustlife AI system with advanced systems biology and big data to model biology and identify viable targets. The platform supports end-to-end workflows, including target discovery, hit identification, lead optimization, and preclinical development. Built as a B2B solution for biopharma and research organizations, it leverages causal AI and a scalable data infrastructure. The company aims to scale drug discovery across major therapeutic areas such as neurodegeneration, oncology, inflammation, and muscle-wasting diseases.